MENSTRUAL FUNCTION IN WOMEN WITH DIAGNOSED THYROID PATHOLOGY AFTER COVID-19

The aim. To study the peculiarities of menstrual function in women of reproductive age, in whom various pathologies of the thyroid gland were detected after suffering from COVID-19. Materials and Methods. A study was conducted on 60 women with menstrual dysfunction and diagnosed thyroid pathology following COVID-19 infection within the last year. The average age was 27.1±0.7 years. General clinical, laboratory, and gynecological examinations were performed, including thyroid ultrasound, and measurements of TSH, free T4, free T3, anti-TPO antibodies, estradiol, and progesterone levels. Results. Thyroid pathology was detected in 43 women (71.7%): subacute thyroiditis in 16 (11.6%), AIT in 38 (88.4%). Menstrual dysfunction in these patients (n=43) included opsomenorrhoea (25.6%), secondary amenorrhea (23.3%), metrorrhagia (16.3%), hypermenorrhea (11.6%), algodismenorrhea (10%), and menorrhagia (14%). Hormonal thyroid profile showed 23.3% with euthyroidism, 69.7% with subclinical hypothyroidism, and 7% with subclinical hyperthyroidism. For subclinical hypothyroidism (n=30), opsomenorrhoea was present in 33.3%, secondary amenorrhea in 26.7%, metrorrhagia in 13.3%, hypermenorrhea in 6.7%, algodismenorrhea in 6.7%, and menorrhagia in 13.3%. For euthyroid status (n=10), opsomenorrhoea was present in 10%, secondary amenorrhea in 20%, metrorrhagia in 10%, hypermenorrhea in 30%, algodismenorrhea in 10%, and menorrhagia in 20%. Hyperthyroidism on the background of AIT was found in 3 women, with metrorrhagia in 2 and algodysmenorrhea in 1. Conclusions. Menstrual dysfunction in women after COVID-19 is a result of thyroid pathology caused by the virus. The main types of menstrual disorders are opsomenorrhoea (25.6%), secondary amenorrhoea (23.3%), metrorrhagia (16.3%), hypermenorrhoea (16.3%), algomenorrhoea (16.3%), and menorrhagia (16.3%). The clinical course varied with thyroid function: subclinical hypothyroidism led to opsomenorrhoea (33.3%) and secondary amenorrhoea (26.7%); euthyroid state resulted in hypermenorrhoea (30%) and secondary amenorrhoea (20%); hyperthyroidism caused metrorrhagia. Early detection and treatment of thyroid disorders can improve women's reproductive health.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-12
DOI
https://doi.org/10.5281/zenodo.13299491
Primary Topic
COVID-19 Impact on Reproduction
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MENSTRUAL FUNCTION IN WOMEN WITH DIAGNOSED THYROID PATHOLOGY AFTER COVID-19

Zenodo (CERN European Organization for Nuclear Research)
COVID-19 Impact on Reproduction
article

MENSTRUAL FUNCTION IN WOMEN WITH DIAGNOSED THYROID PATHOLOGY AFTER COVID-19

article en

Abstract

The aim. To study the peculiarities of menstrual function in women of reproductive age, in whom various pathologies of the thyroid gland were detected after suffering from COVID-19. Materials and Methods. A study was conducted on 60 women with menstrual dysfunction and diagnosed thyroid pathology following COVID-19 infection within the last year. The average age was 27.1±0.7 years. General clinical, laboratory, and gynecological examinations were performed, including thyroid ultrasound, and measurements of TSH, free T4, free T3, anti-TPO antibodies, estradiol, and progesterone levels. Results. Thyroid pathology was detected in 43 women (71.7%): subacute thyroiditis in 16 (11.6%), AIT in 38 (88.4%). Menstrual dysfunction in these patients (n=43) included opsomenorrhoea (25.6%), secondary amenorrhea (23.3%), metrorrhagia (16.3%), hypermenorrhea (11.6%), algodismenorrhea (10%), and menorrhagia (14%). Hormonal thyroid profile showed 23.3% with euthyroidism, 69.7% with subclinical hypothyroidism, and 7% with subclinical hyperthyroidism. For subclinical hypothyroidism (n=30), opsomenorrhoea was present in 33.3%, secondary amenorrhea in 26.7%, metrorrhagia in 13.3%, hypermenorrhea in 6.7%, algodismenorrhea in 6.7%, and menorrhagia in 13.3%. For euthyroid status (n=10), opsomenorrhoea was present in 10%, secondary amenorrhea in 20%, metrorrhagia in 10%, hypermenorrhea in 30%, algodismenorrhea in 10%, and menorrhagia in 20%. Hyperthyroidism on the background of AIT was found in 3 women, with metrorrhagia in 2 and algodysmenorrhea in 1. Conclusions. Menstrual dysfunction in women after COVID-19 is a result of thyroid pathology caused by the virus. The main types of menstrual disorders are opsomenorrhoea (25.6%), secondary amenorrhoea (23.3%), metrorrhagia (16.3%), hypermenorrhoea (16.3%), algomenorrhoea (16.3%), and menorrhagia (16.3%). The clinical course varied with thyroid function: subclinical hypothyroidism led to opsomenorrhoea (33.3%) and secondary amenorrhoea (26.7%); euthyroid state resulted in hypermenorrhoea (30%) and secondary amenorrhoea (20%); hyperthyroidism caused metrorrhagia. Early detection and treatment of thyroid disorders can improve women's reproductive health.

Zenodo (CERN European Organization for Nuclear Research)
Gender equality
Openalex Percentile: Top 58%
COVID-19 Impact on Reproduction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MENSTRUAL FUNCTION IN WOMEN WITH DIAGNOSED THYROID PATHOLOGY AFTER COVID-19 · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS